[96a5a0]: / output / allTrials / identified / NCT03328091_identified.json

Download this file

435 lines (435 with data), 18.4 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
{
"info": {
"nct_id": "NCT03328091",
"official_title": "Genetic Counseling Processes and Outcomes Among Males With Prostate Cancer (ProGen)",
"inclusion_criteria": "* Metastatic prostate cancer (hormone-sensitive, de novo, or castration resistant)\n* Localized prostate cancer with Gleason score ≥8\n* Rising PSA after prostatectomy or radiation with PSA doubling time ≤ 6 months\n* Persistent PSA after prostatectomy for PSA ≥ 0.2 ng/mL observed in testing at least 1 week apart\n* Prostate cancer diagnosed at age ≤ 55 years\n* Prostate cancer and a personal history of prior malignancy that does not include non-melanoma skin cancer or superficial bladder cancer.\n* Prostate cancer diagnosis (any grade/stage) or prostate biopsy with high grade PIN or small acinar proliferation and a family history potentially indicating a germline mutation (e.g. breast cancer diagnosed at age ≤ 50, ovarian, pancreatic, uterine, colorectal, prostate cancer or sarcoma, in one or more first or second-degree relatives)\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Previous cancer genetic testing or counseling, or prior germline multigene panel testing. Previous tumor sequencing is acceptable if no genetic counseling took place.\n* Localized prostate cancer previously treated and in remission for > 2 years unless family history potentially indicates a germline mutation.\n* Active hematologic malignancy (e.g. CLL)",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Metastatic prostate cancer (hormone-sensitive, de novo, or castration resistant)",
"criterions": [
{
"exact_snippets": "Metastatic prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "metastasis",
"expected_value": true
}
]
},
{
"exact_snippets": "hormone-sensitive",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "hormone sensitivity",
"expected_value": "sensitive"
}
]
},
{
"exact_snippets": "de novo",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "disease status",
"expected_value": "de novo"
}
]
},
{
"exact_snippets": "castration resistant",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "castration resistance",
"expected_value": true
}
]
}
]
},
{
"line": "* Localized prostate cancer with Gleason score ≥8",
"criterions": [
{
"exact_snippets": "Localized prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "localization",
"expected_value": "localized"
}
]
},
{
"exact_snippets": "Gleason score ≥8",
"criterion": "Gleason score",
"requirements": [
{
"requirement_type": "score",
"expected_value": {
"operator": ">=",
"value": 8,
"unit": "N/A"
}
}
]
}
]
},
{
"line": "* Rising PSA after prostatectomy or radiation with PSA doubling time ≤ 6 months",
"criterions": [
{
"exact_snippets": "Rising PSA after prostatectomy or radiation",
"criterion": "PSA status",
"requirements": [
{
"requirement_type": "trend",
"expected_value": "rising"
},
{
"requirement_type": "post-treatment",
"expected_value": [
"prostatectomy",
"radiation"
]
}
]
},
{
"exact_snippets": "PSA doubling time ≤ 6 months",
"criterion": "PSA doubling time",
"requirements": [
{
"requirement_type": "time",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Persistent PSA after prostatectomy for PSA ≥ 0.2 ng/mL observed in testing at least 1 week apart",
"criterions": [
{
"exact_snippets": "Persistent PSA after prostatectomy",
"criterion": "persistent PSA after prostatectomy",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "PSA ≥ 0.2 ng/mL",
"criterion": "PSA level",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": ">=",
"value": 0.2,
"unit": "ng/mL"
}
}
]
},
{
"exact_snippets": "observed in testing at least 1 week apart",
"criterion": "PSA testing interval",
"requirements": [
{
"requirement_type": "interval",
"expected_value": "at least 1 week apart"
}
]
}
]
},
{
"line": "* Prostate cancer diagnosed at age ≤ 55 years",
"criterions": [
{
"exact_snippets": "Prostate cancer diagnosed",
"criterion": "prostate cancer diagnosis",
"requirements": [
{
"requirement_type": "age at diagnosis",
"expected_value": {
"operator": "<=",
"value": 55,
"unit": "years"
}
}
]
}
]
},
{
"line": "* Prostate cancer and a personal history of prior malignancy that does not include non-melanoma skin cancer or superficial bladder cancer.",
"criterions": [
{
"exact_snippets": "Prostate cancer",
"criterion": "prostate cancer",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "personal history of prior malignancy",
"criterion": "personal history of prior malignancy",
"requirements": [
{
"requirement_type": "exclusion",
"expected_value": [
"non-melanoma skin cancer",
"superficial bladder cancer"
]
}
]
}
]
},
{
"line": "* Prostate cancer diagnosis (any grade/stage) or prostate biopsy with high grade PIN or small acinar proliferation and a family history potentially indicating a germline mutation (e.g. breast cancer diagnosed at age ≤ 50, ovarian, pancreatic, uterine, colorectal, prostate cancer or sarcoma, in one or more first or second-degree relatives)",
"criterions": [
{
"exact_snippets": "Prostate cancer diagnosis (any grade/stage)",
"criterion": "prostate cancer diagnosis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prostate biopsy with high grade PIN",
"criterion": "high grade PIN",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "prostate biopsy with ... small acinar proliferation",
"criterion": "small acinar proliferation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "family history potentially indicating a germline mutation",
"criterion": "family history of germline mutation",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "breast cancer diagnosed at age ≤ 50",
"criterion": "family history of breast cancer",
"requirements": [
{
"requirement_type": "age of diagnosis",
"expected_value": {
"operator": "<=",
"value": 50,
"unit": "years"
}
}
]
},
{
"exact_snippets": "ovarian, pancreatic, uterine, colorectal, prostate cancer or sarcoma, in one or more first or second-degree relatives",
"criterion": "family history of specific cancers",
"requirements": [
{
"requirement_type": "cancer types",
"expected_value": [
"ovarian",
"pancreatic",
"uterine",
"colorectal",
"prostate",
"sarcoma"
]
},
{
"requirement_type": "relationship",
"expected_value": [
"first-degree relatives",
"second-degree relatives"
]
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be MALE",
"criterions": [
{
"exact_snippets": "MALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "male"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Localized prostate cancer previously treated and in remission for > 2 years unless family history potentially indicates a germline mutation.",
"criterions": [
{
"exact_snippets": "Localized prostate cancer previously treated",
"criterion": "localized prostate cancer",
"requirements": [
{
"requirement_type": "treatment",
"expected_value": "previously treated"
}
]
},
{
"exact_snippets": "Localized prostate cancer ... in remission for > 2 years",
"criterion": "localized prostate cancer",
"requirements": [
{
"requirement_type": "remission duration",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "years"
}
}
]
},
{
"exact_snippets": "family history potentially indicates a germline mutation",
"criterion": "family history",
"requirements": [
{
"requirement_type": "potential germline mutation",
"expected_value": true
}
]
}
]
},
{
"line": "* Active hematologic malignancy (e.g. CLL)",
"criterions": [
{
"exact_snippets": "Active hematologic malignancy",
"criterion": "hematologic malignancy",
"requirements": [
{
"requirement_type": "activity",
"expected_value": "active"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [
{
"line": "* Previous cancer genetic testing or counseling, or prior germline multigene panel testing. Previous tumor sequencing is acceptable if no genetic counseling took place.",
"criterions": [
{
"exact_snippets": "Previous cancer genetic testing",
"criterion": "previous cancer genetic testing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "previous cancer genetic ... prior germline multigene panel testing",
"criterion": "prior germline multigene panel testing",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "Previous tumor sequencing ... if no genetic counseling took place",
"criterion": "previous tumor sequencing without genetic counseling",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
}
],
"failed_miscellaneous": []
}